Trial intelligence / Profile preview

CellCept with Reduced CNI in Liver Transplant

NCT00717314Phase 4Completed

Sponsor
Roche
Start
May 2008
Primary completion
Jul 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of mycophenolate mofetil in Liver transplant rejection, sponsored by Roche. Started May 2008; status: completed.

02

Drugs

mycophenolate mofetil
03

Conditions

Liver transplant rejection

Beyond the preview

Go deeper on NCT00717314.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00717314.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call